Trends and characteristics of ocular exposures related to e-cigarettes and e-liquids reported to Poison Control Centers in the United States, 2010-2019.

Introduction:
This text provides an analysis of trends and characteristics of ocular exposures related to e-cigarettes and e-liquids reported to Poison Control Centers in the United States from 2010-2019. The study aims to describe the patterns and features of ENDS-related ocular exposure cases and trends over time. The study also explores contextual information from case narratives to clarify the nature and circumstances of these cases.

Key Points:

* a total of 1,393 ENDS-related ocular exposure cases were reported to Poison Control Centers during the study period.
* The number of cases increased from two in 2010 to a peak of 389 in 2014, followed by a steady decline in 2015-2018.
* Of the 1,393 cases, 42.5% occurred among individuals aged 25 years and older; 20.4 and 17.7% occurred among young adults aged 18-24 years and children younger than five years, respectively.
* Nearly one quarter (23.8%) of the individuals experiencing ocular exposure sought or were recommended to seek medical attention.
* Case narrative review found that 59 of 127 (46.5%) cases were due, at least in part, to incorrect use or handling of the products.

Main Message:
The study highlights the importance of understanding the health risks associated with e-cigarettes and e-liquids, particularly in relation to ocular exposures. The findings may inform efforts to prevent these exposures by improving awareness of the potential harmful effects of ENDS products and the importance of appropriate handling. healthcare professionals may play an essential role in educating patients and improving surveillance of ENDS-related ocular exposure cases. The study underscores the need for continued monitoring and regulation of these products to protect public health.

Wang B, Liu ST, Johnson Ma, Trigger S. Trends and characteristics of ocular exposures related to e-cigarettes and e-liquids reported to Poison Control Centers in the United States, 2010-2019. Clinical toxicology (Philadelphia, Pa). 2022;60(3):279-285. doi:10.1080/15563650.2021.1951284